Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression
- PMID: 20490631
- PMCID: PMC2886089
- DOI: 10.1007/s10911-010-9178-9
Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression
Abstract
From the earliest stages of embryonic development, cells of epithelial and mesenchymal origin contribute to the structure and function of developing organs. However, these phenotypes are not always permanent, and instead, under the appropriate conditions, epithelial and mesenchymal cells convert between these two phenotypes. These processes, termed Epithelial-Mesenchymal Transition (EMT), or the reverse Mesenchymal-Epithelial Transition (MET), are required for complex body patterning and morphogenesis. In addition, epithelial plasticity and the acquisition of invasive properties without the full commitment to a mesenchymal phenotype are critical in development, particularly during branching morphogenesis in the mammary gland. Recent work in cancer has identified an analogous plasticity of cellular phenotypes whereby epithelial cancer cells acquire mesenchymal features that permit escape from the primary tumor. Because local invasion is thought to be a necessary first step in metastatic dissemination, EMT and epithelial plasticity are hypothesized to contribute to tumor progression. Similarities between developmental and oncogenic EMT have led to the identification of common contributing pathways, suggesting that the reactivation of developmental pathways in breast and other cancers contributes to tumor progression. For example, developmental EMT regulators including Snail/Slug, Twist, Six1, and Cripto, along with developmental signaling pathways including TGF-beta and Wnt/beta-catenin, are misexpressed in breast cancer and correlate with poor clinical outcomes. This review focuses on the parallels between epithelial plasticity/EMT in the mammary gland and other organs during development, and on a selection of developmental EMT regulators that are misexpressed specifically during breast cancer.
Figures






Similar articles
-
Cell polarity in motion: redefining mammary tissue organization through EMT and cell polarity transitions.J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):149-68. doi: 10.1007/s10911-010-9180-2. Epub 2010 May 12. J Mammary Gland Biol Neoplasia. 2010. PMID: 20461450 Review.
-
ErbB/EGF signaling and EMT in mammary development and breast cancer.J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):191-9. doi: 10.1007/s10911-010-9172-2. Epub 2010 Apr 6. J Mammary Gland Biol Neoplasia. 2010. PMID: 20369376 Free PMC article. Review.
-
The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells.J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):169-90. doi: 10.1007/s10911-010-9181-1. Epub 2010 May 15. J Mammary Gland Biol Neoplasia. 2010. PMID: 20467795 Free PMC article. Review.
-
Mammary gland studies as important contributors to the cause of epithelial mesenchymal plasticity in malignancy.J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):113-5. doi: 10.1007/s10911-010-9182-0. J Mammary Gland Biol Neoplasia. 2010. PMID: 20544376 No abstract available.
-
Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer.J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):201-12. doi: 10.1007/s10911-010-9177-x. Epub 2010 May 5. J Mammary Gland Biol Neoplasia. 2010. PMID: 20440544 Free PMC article. Review.
Cited by
-
Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology.J Mol Diagn. 2015 May;17(3):209-24. doi: 10.1016/j.jmoldx.2015.02.001. J Mol Diagn. 2015. PMID: 25908243 Free PMC article. Review.
-
Signal Transduction Pathways of EMT Induced by TGF-β, SHH, and WNT and Their Crosstalks.J Clin Med. 2016 Mar 28;5(4):41. doi: 10.3390/jcm5040041. J Clin Med. 2016. PMID: 27043642 Free PMC article. Review.
-
Effect of CD133 overexpression on the epithelial-to-mesenchymal transition in oral cancer cell lines.Clin Exp Metastasis. 2016 Jun;33(5):487-96. doi: 10.1007/s10585-016-9793-y. Epub 2016 May 2. Clin Exp Metastasis. 2016. PMID: 27137188
-
Stable inhibition of specific estrogen receptor α (ERα) phosphorylation confers increased growth, migration/invasion, and disruption of estradiol signaling in MCF-7 breast cancer cells.Endocrinology. 2012 Sep;153(9):4144-59. doi: 10.1210/en.2011-2001. Epub 2012 Jun 25. Endocrinology. 2012. PMID: 22733972 Free PMC article.
-
MALAT-1 Is a Key Regulator of Epithelial-Mesenchymal Transition in Cancer: A Potential Therapeutic Target for Metastasis.Cancers (Basel). 2024 Jan 4;16(1):234. doi: 10.3390/cancers16010234. Cancers (Basel). 2024. PMID: 38201661 Free PMC article. Review.
References
-
- Shook D, Keller R. Mechanisms, mechanics and function of epithelial-mesenchymal transitions in early development. Mech Dev. 2003;120(11):1351–83. - PubMed
-
- Yamanaka Y, Ralston A, Stephenson RO, Rossant J. Cell and molecular regulation of the mouse blastocyst. Dev Dyn. 2006;235(9):2301–14. - PubMed
-
- Muller HA. Of mice, frogs and flies: generation of membrane asymmetries in early development. Dev Growth Differ. 2001;43(4):327–42. - PubMed
-
- Solnica-Krezel L. Conserved patterns of cell movements during vertebrate gastrulation. Curr Biol. 2005;15(6):R213–28. - PubMed
-
- Hay ED. The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Dev Dyn. 2005;233(3):706–20. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous